貧血治療薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Anemia Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100174)・商品コード:GIR8100174
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年9月27日
・ページ数:121
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、貧血治療薬の世界市場について調べ、まとめました。種類別セグメントは、鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血等、用途別セグメントは、病院、診療所、その他等に区分しました。貧血治療薬の世界市場概観、メーカー動向、メーカー別貧血治療薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・貧血治療薬の市場概観
・貧血治療薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・貧血治療薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・貧血治療薬の世界市場規模
・貧血治療薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・貧血治療薬のアメリカ市場規模推移
・貧血治療薬のカナダ市場規模推移
・貧血治療薬のメキシコ市場規模推移
・貧血治療薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・貧血治療薬のドイツ市場規模推移
・貧血治療薬のイギリス市場規模推移
・貧血治療薬のロシア市場規模推移
・貧血治療薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・貧血治療薬の日本市場規模推移
・貧血治療薬の中国市場規模推移
・貧血治療薬の韓国市場規模推移
・貧血治療薬のインド市場規模推移
・貧血治療薬の東南アジア市場規模推移
・貧血治療薬の南米市場分析(ブラジル、アルゼンチン等)
・貧血治療薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・貧血治療薬の種類別分析/市場規模推移(鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血)
・貧血治療薬の用途別分析/市場規模推移(病院、診療所、その他)
・貧血治療薬の市場予測(地域別予測、種類別予測、用途別予測)
・貧血治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia.

Scope of the Report:

This report studies the Anemia Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anemia Therapeutics market by product type and applications/end industries.

The iron deficiency anemia market segment accounted for the major shares of the anemia drugs market during 2017. The prevalence of iron deficiency anemia is increasing in the developing as well as developed countries. Also, around 5% women and 2% men in America are affected by the iron deficiency anemia as per the National Institutes of Health (NIH)

The global Anemia Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anemia Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Sanofi

Acceleron Pharma

Bayer

GlaxoSmithKline

Novartis

Pieris Pharmaceuticals

AMAG Pharmaceuticals

Daiichi Sankyo

Galenica

Pharmacosmos

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Iron Deficiency Anemia

Sickle Cell Anemia

Pernicious Anemia

Hemolytic Anemia

Market Segment by Applications, can be divided into

Hospitals

Clinics

Others

【レポートの目次】

Table of Contents

1 Anemia Therapeutics Market Overview

1.1 Product Overview and Scope of Anemia Therapeutics

1.2 Classification of Anemia Therapeutics by Types

1.2.1 Global Anemia Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Anemia Therapeutics Revenue Market Share by Types in 2017

1.2.3 Iron Deficiency Anemia

1.2.4 Sickle Cell Anemia

1.2.5 Pernicious Anemia

1.2.6 Hemolytic Anemia

1.3 Global Anemia Therapeutics Market by Application

1.3.1 Global Anemia Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Anemia Therapeutics Market by Regions

1.4.1 Global Anemia Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Anemia Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Anemia Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anemia Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Anemia Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anemia Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Anemia Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Anemia Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Acceleron Pharma

2.2.1 Business Overview

2.2.2 Anemia Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Acceleron Pharma Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bayer

2.3.1 Business Overview

2.3.2 Anemia Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bayer Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Anemia Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Anemia Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Pieris Pharmaceuticals

2.6.1 Business Overview

2.6.2 Anemia Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pieris Pharmaceuticals Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 AMAG Pharmaceuticals

2.7.1 Business Overview

2.7.2 Anemia Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 AMAG Pharmaceuticals Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Daiichi Sankyo

2.8.1 Business Overview

2.8.2 Anemia Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Daiichi Sankyo Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Galenica

2.9.1 Business Overview

2.9.2 Anemia Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Galenica Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pharmacosmos

2.10.1 Business Overview

2.10.2 Anemia Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pharmacosmos Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Anemia Therapeutics Market Competition, by Players

3.1 Global Anemia Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Anemia Therapeutics Players Market Share

3.2.2 Top 10 Anemia Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Anemia Therapeutics Market Size by Regions

4.1 Global Anemia Therapeutics Revenue and Market Share by Regions

4.2 North America Anemia Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Anemia Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Anemia Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Anemia Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Anemia Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Anemia Therapeutics Revenue by Countries

5.1 North America Anemia Therapeutics Revenue by Countries (2013-2018)

5.2 USA Anemia Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Anemia Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Anemia Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Anemia Therapeutics Revenue by Countries

6.1 Europe Anemia Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Anemia Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Anemia Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Anemia Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Anemia Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Anemia Therapeutics Revenue by Countries

7.1 Asia-Pacific Anemia Therapeutics Revenue by Countries (2013-2018)

7.2 China Anemia Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Anemia Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Anemia Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Anemia Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Anemia Therapeutics Revenue by Countries

8.1 South America Anemia Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Anemia Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Anemia Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Anemia Therapeutics by Countries

9.1 Middle East and Africa Anemia Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Anemia Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Anemia Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Anemia Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Anemia Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Anemia Therapeutics Market Segment by Type

10.1 Global Anemia Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Anemia Therapeutics Market Forecast by Type (2018-2023)

10.3 Iron Deficiency Anemia Revenue Growth Rate (2013-2023)

10.4 Sickle Cell Anemia Revenue Growth Rate (2013-2023)

10.5 Pernicious Anemia Revenue Growth Rate (2013-2023)

10.6 Hemolytic Anemia Revenue Growth Rate (2013-2023)

11 Global Anemia Therapeutics Market Segment by Application

11.1 Global Anemia Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Anemia Therapeutics Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Others Revenue Growth (2013-2018)

12 Global Anemia Therapeutics Market Size Forecast (2018-2023)

12.1 Global Anemia Therapeutics Market Size Forecast (2018-2023)

12.2 Global Anemia Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Anemia Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Anemia Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Anemia Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Anemia Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Anemia Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Anemia Therapeutics Picture

Table Product Specifications of Anemia Therapeutics

Table Global Anemia Therapeutics and Revenue (Million USD) Market Split by Product Type

Figure Global Anemia Therapeutics Revenue Market Share by Types in 2017

Figure Iron Deficiency Anemia Picture

Figure Sickle Cell Anemia Picture

Figure Pernicious Anemia Picture

Figure Hemolytic Anemia Picture

Table Global Anemia Therapeutics Revenue (Million USD) by Application (2013-2023)

Figure Anemia Therapeutics Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Clinics Picture

Figure Others Picture

Table Global Market Anemia Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Anemia Therapeutics Type and Applications

Table Sanofi Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Acceleron Pharma Basic Information, Manufacturing Base and Competitors

Table Acceleron Pharma Anemia Therapeutics Type and Applications

Table Acceleron Pharma Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Anemia Therapeutics Type and Applications

Table Bayer Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Anemia Therapeutics Type and Applications

Table GlaxoSmithKline Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Anemia Therapeutics Type and Applications

Table Novartis Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Pieris Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Pieris Pharmaceuticals Anemia Therapeutics Type and Applications

Table Pieris Pharmaceuticals Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table AMAG Pharmaceuticals Anemia Therapeutics Type and Applications

Table AMAG Pharmaceuticals Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table Daiichi Sankyo Anemia Therapeutics Type and Applications

Table Daiichi Sankyo Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Galenica Basic Information, Manufacturing Base and Competitors

Table Galenica Anemia Therapeutics Type and Applications

Table Galenica Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Pharmacosmos Basic Information, Manufacturing Base and Competitors

Table Pharmacosmos Anemia Therapeutics Type and Applications

Table Pharmacosmos Anemia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Global Anemia Therapeutics Revenue (Million USD) by Players (2013-2018)

Table Global Anemia Therapeutics Revenue Share by Players (2013-2018)

Figure Global Anemia Therapeutics Revenue Share by Players in 2016

Figure Global Anemia Therapeutics Revenue Share by Players in 2017

Figure Global Top 5 Players Anemia Therapeutics Revenue Market Share in 2017

Figure Global Top 10 Players Anemia Therapeutics Revenue Market Share in 2017

Figure Global Anemia Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Anemia Therapeutics Revenue (Million USD) by Regions (2013-2018)

Table Global Anemia Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Anemia Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Anemia Therapeutics Revenue Market Share by Regions in 2017

Figure North America Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Europe Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure South America Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Anemia Therapeutics Revenue by Countries (2013-2018)

Table North America Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Anemia Therapeutics Revenue Market Share by Countries in 2017

Figure USA Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Canada Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Mexico Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Anemia Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Europe Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Europe Anemia Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure UK Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure France Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Russia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Italy Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Anemia Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Anemia Therapeutics Revenue Market Share by Countries in 2017

Figure China Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Japan Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Korea Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure India Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Anemia Therapeutics Revenue by Countries (2013-2018)

Table South America Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Anemia Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Argentina Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Colombia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Anemia Therapeutics Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Anemia Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Anemia Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure UAE Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Egypt Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure Nigeria Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Figure South Africa Anemia Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Anemia Therapeutics Revenue (Million USD) by Type (2013-2018)

Table Global Anemia Therapeutics Revenue Share by Type (2013-2018)

Figure Global Anemia Therapeutics Revenue Share by Type (2013-2018)

Figure Global Anemia Therapeutics Revenue Share by Type in 2017

Table Global Anemia Therapeutics Revenue Forecast by Type (2018-2023)

Figure Global Anemia Therapeutics Market Share Forecast by Type (2018-2023)

Figure Global Iron Deficiency Anemia Revenue Growth Rate (2013-2018)

Figure Global Sickle Cell Anemia Revenue Growth Rate (2013-2018)

Figure Global Pernicious Anemia Revenue Growth Rate (2013-2018)

Figure Global Hemolytic Anemia Revenue Growth Rate (2013-2018)

Table Global Anemia Therapeutics Revenue by Application (2013-2018)

Table Global Anemia Therapeutics Revenue Share by Application (2013-2018)

Figure Global Anemia Therapeutics Revenue Share by Application (2013-2018)

Figure Global Anemia Therapeutics Revenue Share by Application in 2017

Table Global Anemia Therapeutics Revenue Forecast by Application (2018-2023)

Figure Global Anemia Therapeutics Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Clinics Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Anemia Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Anemia Therapeutics Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Anemia Therapeutics Revenue Market Forecast (2018-2023)

Figure Europe Anemia Therapeutics Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Anemia Therapeutics Revenue Market Forecast (2018-2023)

Figure South America Anemia Therapeutics Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Anemia Therapeutics Revenue Market Forecast (2018-2023)



【レポートのキーワード】

貧血治療薬、鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血、病院、診療所、その他

★調査レポート[貧血治療薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100174)販売に関する免責事項を必ずご確認ください。
★調査レポート[貧血治療薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆